Loading...
Loading...
OPK| Name | Value |
|---|---|
| Revenues | 182.2M |
| Cost of Revenue | 151.0M |
| Gross Profit | 31.2M |
| Operating Expense | 92.9M |
| Operating I/L | -61.7M |
| Other Income/Expense | 51.1M |
| Interest Income | 0.4M |
| Pretax | -10.6M |
| Income Tax Expense | -0.3M |
| Net Income/Loss | -10.3M |
OPKO Health, Inc. operates in the diagnostics and pharmaceuticals sectors, providing laboratory testing services through BioReference Laboratories and developing novel diagnostic instruments. Its pharmaceutical segment offers treatments for conditions such as secondary hyperparathyroidism, vitamin D insufficiency, type 2 diabetes, and associated obesity. The company also develops and commercializes longer-acting proprietary versions of therapeutic proteins, specialty APIs, pharmaceutical, nutraceutical, veterinary, and ophthalmic products, and generics. Additionally, it imports, markets, distributes, and sells pharmaceutical products in various indications, including cardiovascular products, vaccines, antibiotics, and hormones.
